Irene Schneider
Qualitätssicherung/ Studienkoordination
Kardiologie · Dept. I
Hemodynamic characteristics of bendopnea – pathophysiological basis of a novel symptom in heart failure patients
01.07.2024The present project has several objectives. Our main goal is to evaluate the hemodynamic characteristics in particular the mean pulmonary artery wedge pressure (mPAWP) of patients with versus without bendopnea and those with high (supramedian) vers...
Klinische Forschung - 01.07.2024 - 30.06.2026
Laufend
Projektleitung: Maeder Micha
Mitarbeiter/innen: Schneider Irene
FANTOM
06.05.2024To evaluate the continued safety and performance of the Reva Fantom Sirolismus-Eluting Bioresorbable Coronary Scaffold in nativ coronary arteries that includes incorporation of a deformable expansion technologgy and an enhanced scaffold material (Tyr...
Klinische Forschung - 06.05.2024 - 30.06.2030
Laufend
Projektleitung: Rigger Johannes
Mitarbeiter/innen: Fink Karin, Schneider Irene
The Selution DeNovo Study
28.09.2023A prospective, randomized, multicenter, international, open, clinical study in which the SELUTION DEB strategy was compared with the DES strategy. Study objectives: 1) At 1 year, to demonstrate non-inferiority for TVF of a treatment strategy wi...
Klinische Forschung - 28.09.2023 - 28.09.2028
Laufend
Projektleitung: Rigger Johannes
Mitarbeiter/innen: Meier Jessica, Schneider Irene
Swiss Cardiac Amyloidosis Registry
01.07.2023The aim of the Swiss-CARE registry is a comprehensive collection of clinical data and a follow-up of patients diagnosed with cardiac amyloidosis. Patients with and without therapy will be included in the registry. This will allow us to better under...
Register - 01.07.2023 - 01.07.2033
Laufend
Projektleitung: Ehl Niklas
Mitarbeiter/innen: Schneider Irene
Swiss Secondary Prevention and Rehabilitation Registry: SwissPR
01.07.2023The rationale of this prospective longitudinal cohort study is to determine the short and long-term effects of an ambulatory cardiac rehabilitation program on key cardiovascular benchmark performance measures and its effects on major adverse cardiova...
Register - 01.07.2023 - 31.12.2040
Laufend
Projektleitung: Buser Marc
Mitarbeiter/innen: Schneider Irene
MitraSwiss Register
01.04.2022A longitudinal observational study of patients treated with the MitraClip system in Switzerland
Register - 01.04.2022 - 31.12.2030
Laufend
Projektleitung: Haager Philipp
Mitarbeiter/innen: Schneider Irene
CARE-HK in HF Registry
30.09.2021This study is a multinational, multicentre, non-interventional, cohort study of assessment and treatment guideline recommendations in HF patient care in a real-world setting.
Klinische Forschung - 30.09.2021 - 31.12.2025
Abgeschlossen
Projektleitung: Maeder Micha
Mitarbeiter/innen: Vetsch Susanne, Schneider Irene
ALFA ROMEO
23.06.2021Atrial fibrillation before and after patent foramen ovale closure study This is a prospective, multicenter, single-arm, observational study assessing the incidence, predictors and prognostic impact of AF occurring before (monitoring phase A) or af...
Klinische Forschung - 23.06.2021 - 23.06.2027
Laufend
Projektleitung: Chronis Joannis
Mitarbeiter/innen: Schneider Irene, Vetsch Susanne
CardioOnco - Diagnosing Preclinical Cardiac Dysfunction in Adult Childhood Cancer Survivors ‒ The CardioOnco study
01.03.2021We aim to: 1. Assess preclinical cardiac dysfunction longitudinally using 2-dimensional (2D) and 3-dimensional (3D) conventional and 2D speckle tracking echocardiography. 2. Assess cardiopulmonary fitness using cardiopulmonary exercise testing. 3....
Klinische Forschung - 01.03.2021 - 31.12.2030
Laufend
Projektleitung: Scheler Eva
Mitarbeiter/innen: Schneider Irene
CATCH - Cascade genetic testing of familial hypercholesterolemia: the CATCH multicenter randomized controlled trial
15.12.2020To test in a multicenter open-label randomized controlled trial across Switzerland whether a cascade screening programme for FH, in comparison with usual care, will increase the detection rate of FH within families. The primary outcome will be the...
Klinische Forschung - 15.12.2020 - 31.03.2024
Abgeschlossen
Projektleitung: Rickli Hans
Mitarbeiter/innen: Vetsch Susanne, Schneider Irene
SILENT 2
04.12.2020Incidence of Silent Atrial Fibrillation in Patients With Clinically Silent Brain Ischemic Lesions Arterial Fibrillation (AF) is well-recognized as a cause for cryptogenic Acute Ischemic Stroke (AIS) and is associated with Silent Brain Infarction...
Klinische Forschung - 04.12.2020 - 04.12.2024
Laufend
Projektleitung: Ammann Peter, Kägi Georg
Mitarbeiter/innen: Brenner Roman, Vetsch Susanne, Schneider Irene
SwissSCAD
01.10.2020The primary aim is to gather observational data from consecutive SCAD patients in Switzerland, in order to establish a National Swiss Registry (SwissSCAD). SCAD is a poorly understood condition, affecting young patients and is associated with major...
Klinische Forschung - 01.10.2020 - 31.12.2030
Laufend
Projektleitung: Rickli Hans
Mitarbeiter/innen: Schneider Irene
Cruz HBR
13.07.2020Post-market registry to evaluate the safety and efficacy of the Supraflex Cruz™ sirolimus-eluting coronary stent system in the treatment of all-comer patients with coronary artery disease
Klinische Forschung - 13.07.2020 - 31.12.2022
Abgeschlossen
Projektleitung: Weilenmann Daniel
Mitarbeiter/innen: Schneider Irene, Fink Karin
BIOMASTER BIOMONITOR III
10.02.2020This study is a post-market clinical follow-up (PMCF) study to identify and evaluate residual risks associated with the use of the BIOMONITOR III that are discovered or remain even after risk analysis, risk mitigation and successful conformity assess...
Klinische Forschung - 10.02.2020 - 21.01.2022
Abgeschlossen
Projektleitung: Ammann Peter
Mitarbeiter/innen: Schneider Irene
DPF Coro - Entwicklung einer diagnostischen Probabilitätsfunktion (DPF) bei Patienten mit rezidivierenden Thoraxschmerzen zur Schätzung der Wahrscheinlichkeit einer relevanten koronaren Herzkrankheit
01.02.2019Ziele: Aus den klinischen Daten (Anamnese, körperliche Untersuchung und einem der Ischämietests [Ergometrie, Stress-Echo, Stress MRI) wird mit einer logistischen Regression eine Wahrscheinlichkeits-funktion abgeleitet. Als Referenzuntersuchung gelten...
Klinische Forschung - 01.02.2019 - 31.03.2022
Abgeschlossen
Projektleitung: Rickli Hans
Mitarbeiter/innen: Schneider Irene
iModern
20.01.2019Titel: instantaneous wave-free ratio guided Multivessel revascularizatiOn During percutaneous coronary intervEntion for acute myocaRdial iNfarction Objective: To compare an iFR-guided intervention of noninfarct lesions during the acute interventi...
Klinische Forschung - 20.01.2019 - 31.12.2024
Laufend
Projektleitung: Rigger Johannes
Mitarbeiter/innen: Schneider Irene
BIOSOLVE IV - Safety and Performance in de Novo Lesions of Native Coronary Arteries with Magmaris
01.11.2018The aim of the BIOSOLVE - IV Swiss Satellite Registry is to investigate the clinical performance and long-term safety of Magmaris in a real world setting and extend clinical practice using the technology in a monitored nationwide registry. Primary En...
Klinische Forschung - 01.11.2018 - 31.03.2022
Abgebrochen
Projektleitung: Jörg Lucas
Mitarbeiter/innen: Schneider Irene
Takotsubo - Clinical Characteristics of Takotsubo Cardiomyopathy
01.04.2018Takotsubo Cardiomyopathy, or broken heart syndrome, is a recently described acquired form of cardiomyopathy whose pathophysiology is not well understood and particularly affects postmenopausal women. The exact mechanism is still unclear and large p...
Klinische Forschung - 01.04.2018 - 31.12.2030
Laufend
Projektleitung: Jörg Lucas
Mitarbeiter/innen: Fink Karin, Schneider Irene
WIN: Worldwide registry to assess the STENTYS XPOSITION S for revascularization of coronary arteries In routine cliNical practice
27.01.2017To assess the long term safety and efficacy of the XPOSITION S STENT in routine clinical practice. Inclusion of subjects with coronary artery disease, including patients with chronic stable angina, silent ischemia and acute coronary syndrome, who qua...
Klinische Forschung - 27.01.2017 - 31.01.2020
Abgeschlossen
Projektleitung: Weilenmann Daniel
Mitarbeiter/innen: Schneider Irene
BIOSTEMI und BIOSTEMI Ext
12.10.2016Mit dieser Studie wird die Sicherheit und Effektivität von zwei medikamentenbeschichteten Stents bei Patienten, die einen STEMI erlitten haben verglichen. Es wird geprüft, ob der Stent mit einer selbst auflösenden Beschichtung bei Patienten mit einem...
Klinische Forschung - 12.10.2016 - 30.12.2023
Abgeschlossen
Projektleitung: Weilenmann Daniel
Mitarbeiter/innen: Schneider Irene